Skip to content

What is rotigotine patch used for?

4 min read

According to the European Medicines Agency, the Neupro® (rotigotine transdermal system) patch is used to manage the symptoms of both Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome in adults. This once-daily application provides a continuous, steady delivery of the medication over a 24-hour period, helping to control movement and discomfort.

Quick Summary

Rotigotine patches treat Parkinson's disease symptoms and moderate-to-severe restless legs syndrome by delivering a continuous dose of a dopamine agonist through the skin.

Key Points

  • Dual Indication: Rotigotine patches are approved for treating both Parkinson's disease (PD) symptoms and moderate-to-severe restless legs syndrome (RLS).

  • Continuous Delivery: The transdermal patch provides a steady, 24-hour supply of medication, helping to manage symptoms consistently throughout the day and night.

  • Bypasses Digestive System: As a patch, it avoids the gastrointestinal tract, making it a suitable option for patients who experience swallowing difficulties or GI disturbances.

  • Dopamine Agonist: Rotigotine functions by stimulating dopamine receptors in the brain, which helps to improve motor control and coordination.

  • Requires Tapering: Treatment should not be stopped abruptly, as this can cause a severe withdrawal syndrome with symptoms such as fever, muscle stiffness, and mood changes.

  • Potential for Impulse Control Issues: Patients should be monitored for new or increased urges and compulsive behaviors, including pathological gambling and increased sexual urges.

  • Application Site Rotation: To minimize the risk of skin irritation and side effects, users must rotate the application site daily and not re-use the same spot for 14 days.

In This Article

What is rotigotine patch used for?

The rotigotine transdermal patch, commonly known by its brand name Neupro®, is a prescription medication primarily used for two neurological conditions. Its unique transdermal delivery system ensures a continuous flow of medication, a key benefit for chronic conditions.

  • Parkinson's Disease (PD): Rotigotine is used to treat the signs and symptoms of PD, a progressive neurological disorder that affects movement. The patch can be used as a standalone treatment (monotherapy) in the early stages of the disease or in combination with other medications like levodopa in more advanced stages. It helps manage motor symptoms such as tremors, stiffness, slowed movements (bradykinesia), and balance problems. The steady delivery can also help improve non-motor symptoms like sleep disturbances and mood issues.

  • Restless Legs Syndrome (RLS): The rotigotine patch is also prescribed for moderate-to-severe primary RLS. RLS is a condition that causes an irresistible, often uncomfortable, urge to move the legs, particularly when at rest. The patch's continuous, 24-hour administration helps provide sustained relief from these symptoms, which tend to be more prevalent at night.

How the rotigotine patch works

Rotigotine belongs to a class of drugs called dopamine agonists. The precise mechanism for its therapeutic effect is not fully understood, but it is believed to work by stimulating dopamine receptors in the brain. Dopamine is a chemical messenger (neurotransmitter) that plays a crucial role in controlling movement and coordination. In PD, dopamine-producing brain cells die, leading to decreased dopamine levels. By mimicking dopamine's actions, rotigotine helps compensate for this deficiency and alleviate symptoms. For RLS, rotigotine is also thought to work by stimulating dopamine receptors, as a dopamine system dysfunction is believed to contribute to the syndrome. The transdermal patch allows for steady, non-pulsatile drug delivery, which can provide more consistent symptom control compared to oral medications that cause fluctuating drug levels in the bloodstream.

Comparison of rotigotine with other treatments

Feature Rotigotine Transdermal Patch Oral Dopamine Agonists (e.g., Ropinirole, Pramipexole) Oral Levodopa (for PD)
Route of Administration Once-daily patch application to the skin Oral tablets, typically taken multiple times per day Oral tablets, often timed around meals
Drug Delivery Continuous, steady delivery over 24 hours Pulsatile delivery with fluctuating drug levels Fluctuating delivery, requiring careful timing to manage motor fluctuations
Effect on Swallowing No swallowing required; ideal for patients with dysphagia Requires patients to be able to swallow pills Requires patients to be able to swallow pills
Gastrointestinal Impact Bypasses the digestive system; avoids first-pass metabolism Can cause nausea and vomiting, especially during dose titration Can also cause gastrointestinal side effects
Common Side Effects Application site reactions, nausea, somnolence, dizziness Nausea, vomiting, somnolence, dizziness Dyskinesia (uncontrolled movements) is a common long-term side effect

How to apply and use the rotigotine patch

Proper application of the rotigotine patch is critical for its effectiveness and to minimize skin irritation.

  1. Select the Application Site: Choose a clean, dry, intact, and hairless area of skin. Suitable sites include the abdomen, thigh, hip, side of the body, shoulder, or upper arm.
  2. Prepare the Skin: Do not apply creams, lotions, or oils to the area. If applying to a hairy area, shave it at least three days prior to applying the patch.
  3. Apply the Patch: Apply immediately after opening the protective pouch. Press the patch firmly onto the skin with your palm for about 30 seconds to ensure good contact.
  4. Wear for 24 Hours: The patch should be worn continuously for 24 hours. You can bathe, shower, or swim with it on.
  5. Rotate Sites Daily: After 24 hours, remove the old patch and apply a new one to a different site. Do not use the same site again for at least 14 days.
  6. Avoid External Heat: Do not expose the patch to external heat sources like heating pads, hot tubs, saunas, or direct sunlight, as this can increase drug absorption and cause harm.

Potential risks and side effects

While generally well-tolerated, rotigotine carries a risk of side effects, ranging from common to serious.

Common Side Effects:

  • Application site reactions (redness, itching, swelling)
  • Nausea and vomiting
  • Drowsiness, somnolence, or sleep attacks
  • Dizziness or lightheadedness
  • Headache
  • Edema (swelling of hands, feet, ankles)

Serious Side Effects:

  • Sudden Sleep Onset: Some patients have reported falling asleep without warning during daily activities.
  • Psychosis: Rotigotine can cause or worsen psychotic symptoms, such as hallucinations, confusion, and paranoia.
  • Blood Pressure Changes: Fluctuations in blood pressure can occur, particularly when standing up quickly.
  • Impulse Control Disorders (ICDs): Some individuals may develop unusual or compulsive urges, including pathological gambling, increased sexual urges, or binge eating.
  • Allergic Reactions: Severe allergic reactions are possible, especially in individuals with a sulfite allergy, as the patch contains sodium metabisulfite.
  • Dopamine Agonist Withdrawal Syndrome (DAWS): Abruptly stopping or rapidly tapering the dose can lead to severe withdrawal symptoms like fever, confusion, and muscle stiffness.

Conclusion

In summary, the rotigotine transdermal patch is a valuable treatment option for managing the symptoms of Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome. By offering a continuous, 24-hour dose of a dopamine agonist, it provides a steady level of medication that can be particularly beneficial for controlling motor symptoms and improving quality of life, especially for those with difficulty taking oral medications. However, patients and caregivers should be aware of the potential side effects, including serious risks like sudden sleep onset and impulse control disorders. As with any prescription medication, it is essential to follow a healthcare provider's dosing instructions and never stop the treatment abruptly. You can find more information about this treatment option from the Davis Phinney Foundation.

Frequently Asked Questions

The rotigotine patch (Neupro®) is used for treating the symptoms of Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome in adults.

The patch delivers rotigotine, a dopamine agonist, through the skin over 24 hours. It works by mimicking the effect of dopamine in the brain, helping to regulate movement and coordination.

No, you must not cut or damage the patch. Doing so can affect how the medication is absorbed into the body and may result in an improper dose.

The patch is applied once a day at approximately the same time. The old patch must be removed before a new one is applied.

Common side effects include application site reactions (redness, itching), nausea, sleepiness, dizziness, and headache.

No, you should not stop using the rotigotine patch suddenly. Abrupt discontinuation can cause severe withdrawal symptoms, so the dose must be slowly reduced under a doctor's supervision.

Avoid exposing the patch to external heat, such as heating pads or saunas, as this can cause dangerous overheating and increase drug absorption. Also, inform your doctor if you have an MRI or cardioversion scheduled, as the patch must be removed for these procedures.

The safety of rotigotine during pregnancy has not been established. If you are pregnant or plan to become pregnant, you should consult your doctor.

You should avoid drinking alcohol while using rotigotine, as it can increase side effects like drowsiness and dizziness.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.